Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_assertion type Assertion NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_head.
- NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_assertion description "[Therefore, targeting inflammation along with the newly identified targets, such as MMP10 and S100A15, represents promising therapeutic strategies to treat SCCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_provenance.
- NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_assertion evidence source_evidence_literature NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_provenance.
- NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_assertion SIO_000772 24029918 NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_provenance.
- NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_assertion wasDerivedFrom befree-20150227 NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_provenance.
- NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_assertion wasGeneratedBy ECO_0000203 NP985080.RA_oz4Exr_-7qM75GbQXwNWK5nHa6vWaRC6Qaa2Rii8jw130_provenance.